Eurocrit Labs International Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 3 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 24.55 Cr
- Revenue Growth %
- Profit Growth 1404.85%
- Ebitda 4447.40%
- Net Worth 46.89%
- Total Assets 146.73%
About Eurocrit Labs International
Eurocrit Labs International Private Limited (ELIPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 October 2021 (Three years and four months 13 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹24.55 Cr.
Nikhil Khubchandani and Ankuj Khanna serve as directors at the Company.
Company Details
- Location
Panchkula, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299HR2021PTC098441
- Company No.
098441
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Eurocrit Labs International?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Khubchandani  | Director | 13-Oct-2021 | Current |
| Ankuj Khanna | Director | 13-Oct-2021 | Current |
Financial Performance of Eurocrit Labs International.
Eurocrit Labs International Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1404.85% increase in profit. The company's net worth Soared by an impressive increase of 46.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurocrit Labs International?
In 2024, Eurocrit Labs International had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ahs Life LlpNikhil Khubchandani is a mutual person
- Trumount Pharmaceuticals Private Limited
Nikhil Khubchandani is a mutual person
Charges (Loans)
₹24.55 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 24.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2024 | Others | ₹14.70 Cr | Open |
| 28 Feb 2023 | Others | ₹9.85 Cr | Open |
How Many Employees Work at Eurocrit Labs International?
Eurocrit Labs International has a workforce of 100 employees as of Jan 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurocrit Labs International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurocrit Labs International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.